Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Axsome Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Axsome Therapeutics Inc. June 5, 202673.6%
-
Axsome Therapeutics Inc. June 2, 202363.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 8, 2026 | Axsome Therapeutics Inc. | Option exercise | +1,429 | — | — |
| Dec 31, 2025 | Axsome Therapeutics Inc. | Option exercise | +6,231 | $8.02 | $49,973 |
| Dec 31, 2025 | Axsome Therapeutics Inc. | Open-market sale | −6,231 | $165.18 | $1,029,237 |
| Dec 31, 2025 | Axsome Therapeutics Inc. | Option exercise | +31,346 | $4.95 | $155,163 |
| Dec 31, 2025 | Axsome Therapeutics Inc. | Open-market sale | −31,346 | $165.18 | $5,177,732 |
| Sep 5, 2025 | Axsome Therapeutics Inc. | Option exercise | +9,127 | $9.00 | $82,143 |
| Sep 5, 2025 | Axsome Therapeutics Inc. | Open-market sale | −9,127 | $125.07 | $1,141,514 |
| Sep 11, 2024 | Axsome Therapeutics Inc. | Option exercise | +11,016 | $3.67 | $40,429 |
| Sep 11, 2024 | Axsome Therapeutics Inc. | Open-market sale | −11,016 | $91.31 | $1,005,871 |
Questions about Mark E. Saad
What boards is Mark E. Saad on?
Mark E. Saad sits on the board of Axsome Therapeutics Inc.
How long has Mark E. Saad served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.